scholarly journals Osimertinib in the treatment of leptomeningeal disease in T790M-negative, epidermal growth factor receptor-mutated non-small cell lung cancer: a case report

2019 ◽  
Vol 8 (3) ◽  
pp. 29-29 ◽  
Author(s):  
Julia Chen ◽  
Hussein Soudy
Sign in / Sign up

Export Citation Format

Share Document